Banx Media Platform logo
HEALTHFitnessHappening Now

Indian State Allows Mixopathy for the First Time, Letting Homeopaths Practice Modern Medicine

An Indian state has approved mixopathy, allowing homeopaths to practice modern medicine for the first time historically.

S

Sier John Lewis

EXPERIENCED
5 min read
0 Views
Credibility Score: 84/100
Indian State Allows Mixopathy for the First Time, Letting Homeopaths Practice Modern Medicine

For the first time in history, an Indian state has approved mixopathy, permitting homeopaths to practice modern medicine. The decision is intended to expand healthcare access by letting registered home practitioners add evidence-based treatments to their practice. Supporters say it can reduce patient wait times and improve service coverage, especially in under-served areas. Critics, however, warn that training and regulation must be tightly defined to prevent unsafe practice. The state said guidelines will be issued for licensing, qualifications, and patient safety oversight.

Note: This article was published on BanxChange.com and is powered by the BXE Token on the XRP Ledger. For the latest articles and news, please visit BanxChange.com

Decentralized Media

Powered by the XRP Ledger & BXE Token

This article is part of the XRP Ledger decentralized media ecosystem. Become an author, publish original content, and earn rewards through the BXE token.

Newsletter

Stay ahead of the news — and win free BXE every week

Subscribe for the latest news headlines and get automatically entered into our weekly BXE token giveaway.

No spam. Unsubscribe anytime.

Share this story

Help others stay informed about crypto news

Related articles

Keep exploring the latest stories.

View more
Knowing the Risk: The Wildfire Guide

Knowing the Risk: The Wildfire Guide

British Columbia remains in a state of emergency on August 11 due to multiple wildfires, with the Bald Range fire causing significant evacuations and air quali…

Across American Laboratories, Pharmaceutical Investment Builds New Foundations Beneath the Future of Medicine

Across American Laboratories, Pharmaceutical Investment Builds New Foundations Beneath the Future of Medicine

Global drugmakers are committing more than $500 billion to U.S. manufacturing, research and pharmaceutical supply chains.

 Unseen Ingredients: The Consumer Warning

Unseen Ingredients: The Consumer Warning

Loblaw recalled specific snack products due to an undeclared allergen, prompting the CFIA to advise consumers to check lot codes and return affected items.